Nick Anstey is Professor of Global Health at Menzies School of Health Research in Darwin. He collaborates with partners in Indonesia, Malaysia and across the Asia-Pacific. His team’s research program spans the epidemiology, pathophysiology, treatment and elinination of uncomplicated and severe malaria from the three major species causing malaria deaths in our region: Plasmodium falciparum, P. vivax and P. knowlesi. An author of over 250 publications, he is a member of WHO Technical Expert and Evidence Review Groups in malaria and advises on malaria treatment policy nationally and internationally.Related Projects
- An external quality assurance program for PCR assays to quantify parasitaemia across laboratories in the Asia-Pacific region
- Developing better tools for diagnosing patients and populations at risk of primaquine induced haemolysis
- Developing new diagnostic tests for malaria
- Identifying better treatments for uncomplicated malaria
- Identifying populations at risk of multidrug resistant malaria
- Understanding kinetics of antigens used in rapid diagnostic tests for malaria
Related Publications
- A molecular barcode and web-based data analysis tool to identify imported Plasmodium vivax malaria
- Adults with Plasmodium falciparum malaria have higher magnitude and quality of circulating T-follicular helper cells compared to children
- Age-related clinical spectrum of Plasmodium knowlesi malaria and predictors of severity
- An open dataset of Plasmodium vivax genome variation in 1,895 worldwide samples
- Artemether-lumefantrine versus chloroquine for the treatment of uncomplicated Plasmodium knowlesi malaria: an open-label randomized controlled trial (CAN KNOW)
- Asymptomatic Vivax and Falciparum Parasitaemia with Helminth Co-Infection: Major Risk Factors for Anaemia in Early Life
- Diagnostic performance of a 5-plex malaria immunoassay in regions co-endemic for Plasmodium falciparum, P. vivax, P. knowlesi, P. malariae and P. ovale
- Dihydroartemisinin-piperaquine treatment of multidrug resistant falciparum and vivax malaria in pregnancy
- Efficacy of artesunate-mefloquine for chloroquine-resistant Plasmodium vivax malaria in Malaysia: an open-label randomised controlled trial
- Falling Plasmodium knowlesi malaria death rate among adults despite rising incidence, Sabah, Malaysia, 2010-2014
- Genomic analysis of local variation and recent evolution in Plasmodium vivax
- Genomic Analysis of Plasmodium vivax in Southern Ethiopia Reveals Selective Pressures in Multiple Parasite Mechanisms
- Geographical distribution and genetic diversity of Plasmodium vivax reticulocyte binding protein 1a correlates with patient antigenicity
- Highly effective therapy for maternal malaria associated with a lower risk of vertical transmission
- Increased circulating myeloid-derived suppressor cells in vivax malaria and severe falciparum malaria
- Longitudinal ex vivo and molecular trends of chloroquine and piperaquine activity against Plasmodium falciparum and P. vivax before and after introduction of artemisinin-based combination therapy in Papua, Indonesia
- Loss of complement regulatory proteins on uninfected erythrocytes in vivax and falciparum malaria anemia
- Major burden of severe anemia from non-falciparum malaria species in southern Papua: A hospital-based surveillance study
- Malaria morbidity and mortality following introduction of a universal policy of artemisinin-based treatment for malaria in Papua, Indonesia: A longitudinal surveillance study
- Malaria-related hospitalization during childhood in Papua, Indonesia: A retrospective cohort study
- Parasite Biomass-Related Inflammation, Endothelial Activation, Microvascular Dysfunction and Disease Severity in Vivax Malaria
- Plasmodium malariae and ovale genomes provide insights into malaria parasite evolution
- Population heterogeneity in Plasmodium vivax relapse risk
- Positron emission tomography and magnetic resonance imaging of the brain in experimental human malaria, a prospective cohort study
- Primaquine-induced Severe Hemolysis in the Absence of Concomitant Malaria: Effects on G6PD Activity and Renal Function
- Quantification of parasite clearance in Plasmodium knowlesi infections
- Relationship of circulating Plasmodium falciparum lifecycle stage to circulating parasitemia and total parasite biomass
- The effect of chloroquine dose and primaquine on Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient pooled meta-analysis
- The efficacy of dihydroartemisininpiperaquine and artemether-lumefantrine with and without primaquine on Plasmodium vivax recurrence: A systematic review and individual patient data meta-analysis
- The haematological consequences of Plasmodium vivax malaria after chloroquine treatment with and without primaquine: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis
- Transcriptional profiling and immunophenotyping show sustained activation of blood monocytes in subpatent Plasmodium falciparum infection
- Treatment policy change to dihydroartemisinin-piperaquine contributes to the reduction of adverse maternal and pregnancy outcomes
- Unsupervised primaquine for the treatment of Plasmodium vivax malaria relapses in southern Papua: a hospital-based cohort study